About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
A
EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-Up Dosing Administration - Initial Experiences at Fox Chase Cancer Center BMT Program"
By
Insights from 2023 EHA® Annual Meeting
FEATURING
Asya Varshavsky-Yanovsky
August 4, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:47
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations in R/R CLL - A Patient Case Study
Feat.
J. N. Allan
Featured Video
15:52
Lilly
BTK Inhibition for Patients with MCL: Safety and Efficacy Data
Feat.
J. Pagel
Related Content
AUTOPLAY
ON
18:26
William Schaffner
Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
14:09
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…
Feat.
H. Hashmi
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
03:17
Insights from 2023 IMS Annual Meeting
IMS 2023 Insights: "Highlights From the International Myeloma S…
Feat.
J. Richter
12:33
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myelom…
Feat.
K. Patel
04:15
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…
Feat.
M. Gertz
05:56
ASH 2022 Conference Coverage
ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalido…
Feat.
G. Morgan
13:18
Insights from 2023 IMS Annual Meeting
Highlights and Key Takeaways From the 2023 International Myeloma Soc…
Feat.
A. Jakubowiak
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
13:36
Vanderbilt University Medical Center (VUMC)
Venous Thromboembolism Prophylaxis in Newly Diagnosed MM
Feat.
M. Baljevic
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
05:22
PrecisCa
Teclistamab in R/R Multiple Myeloma: Results From the MajesTEC-1 Tri…
Feat.
A. Nooka
04:31
ASH 2022 Conference Coverage
ASH 2022 GRIFFIN Trial Final Analysis: D-RVd in Clinically Relevant …
Feat.
A. Chari
52:39
Yale Cancer Center
Myeloma in 2023: So Many Drugs, Yet So Few Cures
Feat.
A. Chari
18:27
Indy Hematology Review
DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…
Feat.
J. Mikhael
14:41
Sanofi
Efficacy and Safety of a Treatment Option for Adults with Multiple M…
Feat.
J. Mikhael
